As researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization efforts. However, the space also sees reprimands for abuse by therapists and a pilot attributing almost shutting off plane engines to a “nervous breakdown” caused by shrooms.
Methylphenidate may enhance oculomotor function in individuals with multiple sclerosis
A pilot study conducted by Kessler Foundation researchers has shown promising results in the use of methylphenidate to enhance oculomotor function in individuals with multiple
June 26, 2024